Ritodrine hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for ritodrine hydrochloride and what is the scope of freedom to operate?

Ritodrine hydrochloride is the generic ingredient in three branded drugs marketed by Abraxis Pharm, Hospira, and Astrazeneca, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for ritodrine hydrochloride.

Summary for ritodrine hydrochloride

US Patents:	0
Tradenames:	3
Applicants:	3
NDAs:	7
Drug Master File Entries:	1
Raw Ingredient (Bulk) Api Vendors:	104
Clinical Trials:	10
Patent Applications:	779
DailyMed Link:	ritodrine hydrochloride at DailyMed

Recent Clinical Trials for ritodrine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assiut University	Phase 3
Assiut University	Phase 4
Assiut University	N/A

See all ritodrine hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for ritodrine hydrochloride

Adrenergic beta-2 Receptor Agonists
Sympathomimetics
Tocolytic Agents

Anatomical Therapeutic Chemical (ATC) Classes for ritodrine hydrochloride

G02CA	Sympathomimetics, labour repressants
G02C	OTHER GYNECOLOGICALS
G02	OTHER GYNECOLOGICALS
G	Genito-urinary system and sex hormones

US Patents and Regulatory Information for ritodrine hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Astrazeneca	YUTOPAR	ritodrine hydrochloride	TABLET;ORAL	018555-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abraxis Pharm	RITODRINE HYDROCHLORIDE	ritodrine hydrochloride	INJECTABLE;INJECTION	071189-001	Jul 23, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Astrazeneca	YUTOPAR	ritodrine hydrochloride	INJECTABLE;INJECTION	018580-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ritodrine hydrochloride

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Astrazeneca	YUTOPAR	ritodrine hydrochloride	INJECTABLE;INJECTION	018580-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Astrazeneca	YUTOPAR	ritodrine hydrochloride	TABLET;ORAL	018555-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Astrazeneca	YUTOPAR	ritodrine hydrochloride	INJECTABLE;INJECTION	018580-002	Sep 27, 1984	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.